- Home
- AAP vs RARE Comparison
AAP vs RARE Comparison
Compare AAP & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AAP | RARE |
|---|---|---|
| Founded | 1929 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto & Home Supply Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.3B |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AAP | RARE |
|---|---|---|
| Price | $52.13 | $22.08 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 17 | 19 |
| Target Price | $53.50 | ★ $66.32 |
| AVG Volume (30 Days) | ★ 2.0M | 1.9M |
| Earning Date | 05-14-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.93% | N/A |
| EPS Growth | ★ 113.01 | 7.31 |
| EPS | ★ 0.73 | N/A |
| Revenue | ★ $8,601,000,000.00 | $673,000,000.00 |
| Revenue This Year | $0.55 | $17.23 |
| Revenue Next Year | $2.46 | $36.13 |
| P/E Ratio | $71.41 | ★ N/A |
| Revenue Growth | N/A | ★ 20.13 |
| 52 Week Low | $28.89 | $18.41 |
| 52 Week High | $70.00 | $41.11 |
Technical Indicators
Market Signals| Indicator | AAP | RARE |
|---|---|---|
| Relative Strength Index (RSI) | 49.08 | 42.33 |
| Support Level | $50.98 | $22.00 |
| Resistance Level | $53.13 | $23.79 |
| Average True Range (ATR) | 3.16 | 1.24 |
| MACD | -0.82 | 0.16 |
| Stochastic Oscillator | 15.04 | 53.98 |
Price Performance
Historical ComparisonAbout AAP Advance Auto Parts Inc.
Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on the basis of inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.